Discussion around the effects of a cannabinoid receptor 1 antagonist on THC-induced vascular inflammation

Please join us for a conversation about a study published in 2022 in the Journal Cell entitled: “Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation”, in which Dr. Chandy, and Dr. Sitbon discuss the potential therapeutic applications of genistein, a soybean isoflavone, on inflammation, oxidative stress and vascular dysfunction caused by Δ9-THC administration.